ArticleAnnals of hematology2025

Targeting the akt/mtor signaling pathway by maprotiline leads to tumor suppression in T-cell lymphoma.

Xiaodong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.